Cutting‐Edge Technologies to Decode Tumor Microenvironment in Multiple Myeloma
Hematological Oncology · 2026-03 · 44 (2)
DOI: 10.1002/hon.70171 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematological Oncology, online erschienen am 08.02.2026. Verfasst von Doriana Gramegna und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Tumor Microenvironment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Multiple myeloma (MM) is recognized as a malignancy shaped by its complex tumor microenvironment (TME), which fuels disease progression and therapeutic resistance. Recent advances in single‐cell omics, spatial transcriptomics, mass cytometry, and advanced imaging have enabled high‐resolution mapping of tumor and immune cell interactions within their native context, also revealing spatial heterogeneity that influences clinical outcomes. These tools, complemented by scalable computational frameworks and artificial intelligence, provide cost‐effective alternatives to dissect immune landscapes and derive prognostic biomarkers from both bulk and single‐cell data. However, technical complexity, resource demands, and the need for robust standardization limit their immediate clinical application. On the other hand, machine learning techniques enhance integration and predictive power of existing datasets, supporting the development of personalized, immune‐informed therapeutic strategies. This review highlights recent advances, discusses the strengths and limitations of emerging technologies with a particular focus on their integration to decipher TME biology and pave the way toward precision medicine in MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
- Department of Mathematics, University of Bari Aldo Moro, Bari, Italy.
- Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy.
- Clinic of Hematology, Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
ORCID-Profile: Doriana Gramegna, Sabino Ciavarella
Förderung
- Ministero della Salute
Zitieren
APA
Gramegna, D., Mondelli, P., Pappagallo, S. A., Gargano, G., Vegliante, M. C., Quinto, A. M., Rossini, B., Pasciolla, G., Roccaro, A. M., Cea, M., Iaccino, E., Guarini, A., & Ciavarella, S. (2026). Cutting‐Edge Technologies to Decode Tumor Microenvironment in Multiple Myeloma. Hematological Oncology, 44(2). https://doi.org/10.1002/hon.70171
Vancouver
Gramegna D, Mondelli P, Pappagallo SA, Gargano G, Vegliante MC, Quinto AM, et al. Cutting‐Edge Technologies to Decode Tumor Microenvironment in Multiple Myeloma. Hematological Oncology. 2026;44(2). doi:10.1002/hon.70171
BibTeX
@article{Gramegna2026,
author = {Gramegna, Doriana and Mondelli, Paolo and Pappagallo, Susanna Anita and Gargano, Grazia and Vegliante, Maria Carmela and Quinto, Angela Maria and Rossini, Bernardo and Pasciolla, Gianvito and Roccaro, Aldo Maria and Cea, Michele and Iaccino, Enrico and Guarini, Attilio and Ciavarella, Sabino},
title = {Cutting‐Edge Technologies to Decode Tumor Microenvironment in Multiple Myeloma},
journal = {Hematological Oncology},
year = {2026},
volume = {44},
number = {2},
doi = {10.1002/hon.70171}
}
EUVIMED